Digital surgery firm, Boston-based Caresyntax, has announced a strategic partnership with medical education firm, Woodbury, Connecticut-based CineMed, Inc.
Digital Surgery Firm Partners With Med Education Firm
1 min read Premium comments
Secondary#caresyntax#cinemed#digitalsurgery
Caresyntax’s “digital surgery platform” analyzes operating room data to provide insights to the entire care team. It recently closed a $130 million Series C funding round. For OTW’s coverage of the funding, see “Operating Room Software Company Raises $130 Mllion.”
According to the company, CineMed offers broadcast and video production, online training and education, mobile and web development, customer engagement, event management, Continuing Medical Education (CME) accreditation, analytics, and medical publishing.
The partnership will build off Caresyntax’s platform and CineMed’s service offerings.
Beginning in 2022, according to the company’s public announcements, surgeons will be able to use Caresyntax’s platform to obtain CME credits and “receive online participation summaries on a quarterly basis to support their board certification, state licensure, and hospital credentialing processes.”
OTW spoke with Caresyntax Global Chief Medical Officer Michael Woods, M.D., MMM about the partnership and its strategy to compete with the existing organizations that already offer CME credit. Dr. Woods told OTW, “Caresyntax provides a unique offering beyond CME obtained by just sitting in a conference or reading a journal article. It’s an important distinction, because using our digital platform will help surgeons improve technical skills and overall outcomes. Simply by using our software, they’re checking two boxes with one activity: performance improvement for their patients’ benefit and CME requirements for licensure. As many clinicians struggle with pandemic-related burnout, Caresyntax is committed to reducing clinician burden and supporting the important work surgeons do by making their day a little easier.”
Dr. Woods also discussed the partnership’s goals for the upcoming year, informing OTW, “ We’re looking forward to supporting our network of more than 30,000 surgeons worldwide to make surgery smarter and safer. As our partnership with CineMed expands over the upcoming year, we’ll be able to serve more surgeons’ continuing education needs.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.